Michael J. Browning

6.4k total citations · 1 hit paper
77 papers, 3.1k citations indexed

About

Michael J. Browning is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Michael J. Browning has authored 77 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 16 papers in Epidemiology and 14 papers in Genetics. Recurrent topics in Michael J. Browning's work include T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (26 papers) and Immunotherapy and Immune Responses (23 papers). Michael J. Browning is often cited by papers focused on T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (26 papers) and Immunotherapy and Immune Responses (23 papers). Michael J. Browning collaborates with scholars based in United Kingdom, United States and India. Michael J. Browning's co-authors include P. Krausa, Michael Bunce, Martin Barnardo, Peter J. Morris, K. I. Welsh, Walter F. Bodmer, Peter Krausa, J. G. Bodmer, Andrew Rowan and D C Bicknell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Michael J. Browning

76 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)

1995 903 citations Michael Bunce, P. Krausa et al. Tissue Antigens profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Browning United Kingdom	26	1.8k	617	526	412	286	77	3.1k
Angela Battistini Italy	32	1.5k 0.8×	1.0k 1.6×	822 1.6×	460 1.1×	177 0.6×	114	3.2k
Gilberto Filaci Italy	34	2.0k 1.1×	843 1.4×	632 1.2×	385 0.9×	218 0.8×	121	4.1k
Luisa Imberti Italy	32	2.2k 1.2×	596 1.0×	745 1.4×	642 1.6×	583 2.0×	156	3.8k
Elizabeth Ingulli United States	28	3.0k 1.7×	790 1.3×	523 1.0×	287 0.7×	282 1.0×	65	4.6k
Ali Ahmad Canada	36	1.7k 1.0×	757 1.2×	528 1.0×	664 1.6×	194 0.7×	105	3.4k
Christophe Parizot France	22	3.0k 1.6×	459 0.7×	702 1.3×	540 1.3×	203 0.7×	49	4.5k
Kiki Tesselaar Netherlands	33	3.8k 2.1×	787 1.3×	783 1.5×	732 1.8×	305 1.1×	85	5.2k
Giovanni Melioli Italy	35	2.6k 1.4×	595 1.0×	914 1.7×	526 1.3×	131 0.5×	161	4.9k
Kazunaga Agematsu Japan	42	3.2k 1.8×	1.3k 2.1×	427 0.8×	632 1.5×	468 1.6×	135	5.1k
Kyriaki Dunussi‐Joannopoulos United States	17	2.9k 1.6×	496 0.8×	794 1.5×	305 0.7×	264 0.9×	29	3.7k

Countries citing papers authored by Michael J. Browning

Since Specialization

Citations

This map shows the geographic impact of Michael J. Browning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Browning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Browning more than expected).

Fields of papers citing papers by Michael J. Browning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Browning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Browning. The network helps show where Michael J. Browning may publish in the future.

Co-authorship network of co-authors of Michael J. Browning

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Browning. A scholar is included among the top collaborators of Michael J. Browning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Browning. Michael J. Browning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abu-rish, Eman Y., Eman Elayeh, & Michael J. Browning. (2019). Physicians’ knowledge, attitudes and practices towards Zika virus infection in Jordan. The Journal of Infection in Developing Countries. 13(7). 584–590. 4 indexed citations

Schatorjé, Ellen, Michiel van der Flier, Mikko Seppänen, et al.. (2016). Primary immunodeficiency associated with chromosomal aberration – an ESID survey. Orphanet Journal of Rare Diseases. 11(1). 110–110. 16 indexed citations

Mohamed, Yehia S., Layla Bashawri, Chittibabu Vatte, et al.. (2016). The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation. Molecular Immunology. 77. 79–88. 11 indexed citations

Hobkirk, James, et al.. (2015). On the Functional Overlap between Complement and Anti-Microbial Peptides. Frontiers in Immunology. 5. 689–689. 17 indexed citations

Browning, Michael J.. (2013). Antigen presenting cell/ tumor cell fusion vaccines for cancer immunotherapy. Human Vaccines & Immunotherapeutics. 9(7). 1545–1548. 15 indexed citations

Mohamed, Yehia S., Debbie Dunnion, Iryna Teobald, Renata Walewska, & Michael J. Browning. (2011). Long-lived fusions of human haematological tumour cells and B-lymphoblastoid cells induce tumour antigen-specific cytotoxic T-cell responses in vitro. Immunobiology. 217(7). 719–729. 7 indexed citations

Assaf, Areej M., et al.. (2009). A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines. Cellular Immunology. 259(1). 90–99. 17 indexed citations

Teobald, Iryna, et al.. (2006). Hybrid cells formed by fusion of Epstein – Barr virus‐associated B‐lymphoblastoid cells and either marrow‐derived or solid tumour‐derived cell lines display different co‐stimulatory phenotypes and abilities to activate allogeneic T‐cell responses in vitro. Tissue Antigens. 68(2). 115–126. 6 indexed citations

O’Byrne, Kenneth J., Angus Dalgleish, Michael J. Browning, William P. Steward, & Adrian L. Harris. (2000). The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Faculty of Health; Institute of Health and Biomedical Innovation. 7 indexed citations

10.

Krausa, P., Christian Münz, Wieland Keilholz, et al.. (2000). Definition of peptide binding motifs amongst the HLA‐A*30 allelic group. Tissue Antigens. 56(1). 10–18. 18 indexed citations

11.

Jenkins, Jennifer, et al.. (2000). T‐cell telomere length maintained in HIV‐infected long‐term survivors. HIV Medicine. 1(2). 116–122. 9 indexed citations

12.

O’Byrne, Kenneth J., Angus Dalgleish, Michael J. Browning, William P. Steward, & Adrian L. Harris. (2000). The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. European Journal of Cancer. 36(2). 151–169. 154 indexed citations

13.

Dalgleish, Angus & Michael J. Browning. (1996). Tumor immunology : immunotherapy and cancer vaccines. Cambridge University Press eBooks. 6 indexed citations

14.

Browning, Michael J. & Peter Krausa. (1996). Genetic diversity of HLA-A2: evolutionary and functional significance. Immunology Today. 17(4). 165–170. 81 indexed citations

15.

Krausa, P. & Michael J. Browning. (1996). HLA‐A2 POLYMORPHISM AND IMMUNE FUNCTIONS. International Journal of Immunogenetics. 23(4). 261–274. 15 indexed citations

16.

Imreh, Márta P., Pedro O. de Campos‐Lima, Stephan Imreh, et al.. (1995). Mechanisms of allele‐selective down‐regulation of HLA class I in Burkitt's lymphoma. International Journal of Cancer. 62(1). 90–96. 24 indexed citations

17.

Carcassi, Carlo, P. Krausa, J. G. Bodmer, L. Contu, & Michael J. Browning. (1995). Characterization of HLA‐A*02 subtypes in the Sardinian population. Tissue Antigens. 46(5). 391–393. 9 indexed citations

18.

Krausa, Peter, Walter F. Bodmer, & Michael J. Browning. (1993). Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens. 42(2). 91–99. 61 indexed citations

19.

Beatty, Julia A., et al.. (1992). A recombinant feline immunodeficiency virus envelope fusion protein stimulates peripheral blood lymphocytes from naive cats to proliferate in vitro. Veterinary Immunology and Immunopathology. 35(1-2). 143–153. 4 indexed citations

20.

Browning, Michael J., Alice Huang, & Carol Shoshkes Reiss. (1990). Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.. The Journal of Immunology. 145(3). 985–994. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact